| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |